Quality-of-Life Outcomes for Patients Taking Opioids and Psychotropic Medications Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ian SolskyAna PatelCristian D ValenzuelaGregory RussellKathleen PerryKatie DuckworthKonstantinos I VotanopoulosPerry ShenEdward A LevinePublished in: Annals of surgical oncology (2023)
Despite worse baseline QoL, patients who took opioids/psychotropic medications had QoL scores 1 year postoperatively similar to the scores of those who did not except in the emotional domains. These data point to the potential utility of a timed psychosocial intervention to enhance emotional adaptation and further support the role of CRS-HIPEC in improving QoL.
Keyphrases
- end stage renal disease
- chronic pain
- pain management
- ejection fraction
- randomized controlled trial
- minimally invasive
- chronic kidney disease
- mental health
- prognostic factors
- peritoneal dialysis
- electronic health record
- metabolic syndrome
- coronary artery disease
- patient reported outcomes
- human health
- acute coronary syndrome
- weight loss
- rectal cancer
- artificial intelligence
- patient reported